Tarsus to Present at Upcoming Investor Conferences
March 09 2022 - 5:00PM
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to
focus on unmet needs and apply proven science and new technology to
revolutionize treatment for patients, starting with eye care, today
announced management will present at the following conferences:
- Oppenheimer’s 32nd Annual Healthcare Conference on Wednesday,
March 16, 2022
- Virtual Fireside Chat at 9:40am PT / 12:40pm ET
- Barclays Global Healthcare Conference 2022 on Wednesday, March
16, 2022
- In-person Corporate Presentation at 1:50pm PT / 4:50pm ET
The above listed date and times are subject to
change. Details on the presentation times or changes to the
presentation date can be found on the Company's website. Please
check www.tarsusrx.com for the latest information.
A live webcast of the presentations will also be available on
the events section of the Tarsus website. The replay will be
available within 48 hours and will be archived for a limited
time.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new
technology to revolutionize treatment for patients, starting with
eye care. It is advancing its pipeline to address several diseases
with high unmet need across a range of therapeutic categories,
including eye care, dermatology, and infectious disease prevention.
The company is studying two investigational medicines in clinical
trials. Its lead product candidate, TP-03, is a novel therapeutic
being studied in a second Phase 3 pivotal trial for the treatment
of Demodex blepharitis. TP-03 is also being developed for the
treatment of Meibomian Gland Disease. Tarsus is developing TP-05,
an oral, non-vaccine therapeutic for the prevention of Lyme
disease, which is currently being studied in a Phase 1b clinical
trial.
Contacts: Media Contact:SuJin Oh
twelvenote(917) 841-5213soh@twelvenote.com
Investor Contact:David NakasoneHead of Investor Relations(949)
620-3223DNakasone@tarsusrx.com
Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
From Apr 2023 to Apr 2024